About three years before counterfeit copies of Roche Holding AG's cancer
drug Avastin surfaced in the U.S., a case in Syria involved fakes of
the same drug, showing the company has been grappling with bootlegging
of the product for some time.
More at the link.
http://online.wsj.com/article/SB10001424052970204778604577239462185891798.html?ru=yahoo&mod=yahoo_hs
